Cargando…
Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
BACKGROUND: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesopha...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658928/ https://www.ncbi.nlm.nih.gov/pubmed/29073917 http://dx.doi.org/10.1186/s13014-017-0900-2 |
_version_ | 1783274077261135872 |
---|---|
author | Liu, Jie Zhang, Ye Li, Zhengjiang Liu, Shaoyan Li, Huizheng Xu, Zhengang |
author_facet | Liu, Jie Zhang, Ye Li, Zhengjiang Liu, Shaoyan Li, Huizheng Xu, Zhengang |
author_sort | Liu, Jie |
collection | PubMed |
description | BACKGROUND: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. METHODS: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. RESULTS: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery ≤6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. CONCLUSIONS: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy. |
format | Online Article Text |
id | pubmed-5658928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56589282017-10-31 Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy Liu, Jie Zhang, Ye Li, Zhengjiang Liu, Shaoyan Li, Huizheng Xu, Zhengang Radiat Oncol Research BACKGROUND: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. METHODS: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. RESULTS: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery ≤6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. CONCLUSIONS: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy. BioMed Central 2017-10-26 /pmc/articles/PMC5658928/ /pubmed/29073917 http://dx.doi.org/10.1186/s13014-017-0900-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Liu, Jie Zhang, Ye Li, Zhengjiang Liu, Shaoyan Li, Huizheng Xu, Zhengang Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy |
title | Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy |
title_full | Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy |
title_fullStr | Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy |
title_full_unstemmed | Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy |
title_short | Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy |
title_sort | benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658928/ https://www.ncbi.nlm.nih.gov/pubmed/29073917 http://dx.doi.org/10.1186/s13014-017-0900-2 |
work_keys_str_mv | AT liujie benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy AT zhangye benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy AT lizhengjiang benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy AT liushaoyan benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy AT lihuizheng benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy AT xuzhengang benefitofsalvagetotalpharyngolaryngoesophagectomyforrecurrentlocallyadvancedheadandneckcancerafterradiotherapy |